Discounted Cash Flow

Select Medical Holdings Corp.

SEM · Based on 10 years of SEC filings

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

Free cash flow growth
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI)
10-year: — 5-year: — 3-year: —
Net income growth
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations)
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2016 $4.2b $115.4m $346.6m 2.7% $0.88
2017 $4.4b (3.5%) $177.2m (53.5%) $238.1m (-31.3%) 4.1% (48.3%) $1.33 (51.1%)
2018 $5.1b (16.4%) $137.8m (-22.2%) $494.2m (107.5%) 2.7% (-33.2%) $1.02 (-23.3%)
2019 $5.5b (7.3%) $148.4m (7.7%) $445.2m (-9.9%) 2.7% (0.3%) $1.10 (7.8%)
2020 $5.5b (1.4%) $259.0m (74.5%) $1.0b (130.9%) 4.7% (72.0%) $1.93 (75.5%)
2021 $6.2b (12.2%) $402.2m (55.3%) $401.2m (-61.0%) 6.5% (38.5%) $2.98 (54.4%)
2022 $6.3b (2.1%) $159.0m (-60.5%) $94.5m (-76.5%) 2.5% (-61.3%) $1.23 (-58.7%)
2023 $6.7b (5.2%) $243.5m (53.1%) $352.9m (273.6%) 3.7% (45.5%) $1.91 (55.3%)
2024 $5.2b (-22.2%) $214.0m (-12.1%) $295.7m (-16.2%) 4.1% (12.9%) $1.66 (-13.1%)
2025 $5.5b (5.1%) $146.2m (-31.7%) $117.2m (-60.3%) 2.7% (-35.0%) $1.16 (-30.1%)

Base FCF: (latest fiscal year)

Discount rate: %

Terminal growth:

Projection period: years

Alt A decline yrs:

Alt B total yrs:

Values abbreviated: b = billions, m = millions, k = thousands.

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF:

Terminal FCF:

Terminal value:

PV of terminal value:

Enterprise value (DCF):

DCF price per share:

Current price:

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) 10 + TV
Alt A (Gradual Decline)
Alt B (30yr Hard Stop) N/A

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model